文献速递药物不良反应与药物警戒治疗药物监测与药物基因组学

他汀使用者转氨酶升高后肌酸激酶随访检测与消化科转诊的频率

Patients on statins with elevated transaminases: Frequency of follow-up creatine kinase testing and gastroenterology referral.
PubMed 文献 · Br J Clin Pharmacol · 2026-05-03

该研究回顾性分析了大型医疗系统5年内806例首次出现ALT/AST升高的成人他汀门诊患者,仅22.8%(184/806)在30天内检测了肌酸激酶(CK),其中15.8%(29/184)CK高于正常上限。未及时检测CK者中4.7%(29/619)在60天内转诊消化科,比例与CK升高者相近,提示部分肝脏检查可能可以避免。

要点

  • 他汀使用者新发转氨酶升高后CK检测率低,30天内仅22.8%。
  • 检测者中15.8% CK高于正常上限,提示存在未识别的生化性肌损伤。
  • 首次转氨酶异常时反射性检测CK或可减少不必要的消化科转诊。

核心结论

  • 他汀使用者新发ALT/AST升高后CK检测不频繁,但相当一部分存在生化性肌病,反射性CK检测可能提高诊断准确性并减少不必要的消化科转诊。

研究设计与样本

  • 大型医疗系统成人他汀门诊患者的回顾性病历审查,纳入5年内首次出现ALT/AST升高的806例患者。
  • 主要结局为30天内CK检测;次要结局包括CK升高率和60天内消化科转诊。

主要发现

  • 22.8%(184/806)在30天内检测CK,中位9天(IQR 5-17)。
  • 检测者中15.8%(29/184)CK高于正常上限,占全队列3.6%(29/806)。
  • 无横纹肌溶解、急性肾损伤或住院记录。
  • 未及时检测CK者中4.7%(29/619)在60天内转诊消化科,占全队列3.6%。

临床怎么用

  • 他汀使用者首次出现ALT/AST升高时,可考虑反射性检测CK以区分肌源性转氨酶升高。
  • 在缺乏肌肉特异性检测时,应审慎评估消化科转诊的必要性,避免不必要检查并维持有效降脂治疗。

局限性

  • 为单中心回顾性病历审查,仅能提示关联而无法确立因果。
  • CK检测与转诊行为受临床实践差异影响,可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To quantify how often creatine kinase (CK) is measured after newly elevated aminotransferases in statin users, and whether absent CK data are associated with gastroenterology (GI) referrals. METHODS: Retrospective chart review of adult outpatients on statins with a first alanine/aspartate aminotransferase (ALT/AST) elevation during a 5-year period at a large health system. The primary outcome was CK testing within 30 days; secondary outcomes included CK elevation rate and GI referral within 60 days. RESULTS: Among 806 eligible patients, 22.8% (184/806) had CK measured within 30 days (median 9 days; IQR 5-17). Of those tested, 15.8% (29/184) had CK above the upper limit of normal (ULN); 3.6% (29/806) of the entire cohort therefore had unrecognized biochemical evidence of muscle injury. None had documented rhabdomyolysis, acute kidney injury or hospitalization. Among patients without timely CK testing (619/806), 4.7% (29/619) were referred to GI within 60 days; this proportion (3.6% of the total cohort) mirrored the fraction with CK elevation, suggesting potentially avoidable hepatic work-ups in the absence of muscle-specific testing. CONCLUSIONS: In routine practice, CK is infrequently measured after new ALT/AST elevations in statin users, yet a non-trivial subset has biochemical myopathy. Reflex CK testing at the first abnormal transaminase could improve diagnostic accuracy and reduce unnecessary GI referrals while preserving effective lipid-lowering therapy. Prospective evaluation of reflex-testing pathways and tailored statin selection/dosing is warranted.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Shweikeh F, Kartoumah A, Joshi R, et al. Patients on statins with elevated transaminases: Frequency of follow-up creatine kinase testing and gastroenterology referral. Br J Clin Pharmacol. 2026. PMID: 42070773. doi:10.1002/bcp.70581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。